Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease (2020)
- Authors:
- USP affiliated authors: LARA, VANESSA SOARES - FOB ; SANTOS, CARLOS FERREIRA DOS - FOB
- Unidade: FOB
- DOI: 10.3389/fphar.2020.579926
- Subjects: RECEPTORES DE ANGIOTENSINA; RATOS; DOENÇAS PERIODONTAIS; HIPERTENSÃO; MICROTOMOGRAFIA; OSTEOCLASTO; OSSO E OSSOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 11, art. 579926, 2020
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
BRITO, Victor Gustavo Balera et al. Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease. Frontiers in Pharmacology, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.579926. Acesso em: 19 abr. 2024. -
APA
Brito, V. G. B., Patrocinio, M. S., Sousa, M. C. L. de, Barreto, A. E. A., Frasnelli, S. C. T., Lara, V. S., et al. (2020). Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease. Frontiers in Pharmacology, 11. doi:10.3389/fphar.2020.579926 -
NLM
Brito VGB, Patrocinio MS, Sousa MCL de, Barreto AEA, Frasnelli SCT, Lara VS, Santos CF dos, Oliveira SHP. Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease [Internet]. Frontiers in Pharmacology. 2020 ; 11[citado 2024 abr. 19 ] Available from: https://doi.org/10.3389/fphar.2020.579926 -
Vancouver
Brito VGB, Patrocinio MS, Sousa MCL de, Barreto AEA, Frasnelli SCT, Lara VS, Santos CF dos, Oliveira SHP. Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease [Internet]. Frontiers in Pharmacology. 2020 ; 11[citado 2024 abr. 19 ] Available from: https://doi.org/10.3389/fphar.2020.579926 - Role of mast cell and RAS in mice periodontal tissue
- Mast cells supernatant inhibit bone formation markers gene expression in SHR osteoblasts
- Mast cells contribute to alveolar bone loss in Spontaneously Hypertensive Rats with periodontal disease regulating cytokines production
- Corrigendum: Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease
- Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats
- Aliskiren attenuates the inflammatory response and wound healing process in diabetic mice with periodontal disease
- Mast cells increase gene expression of osteoclastogenic markers in SHR
- Morphologic evaluation and expression of matrix metalloproteinases-2 and 9 and nitric oxide during experimental periodontal disease in rat
- Losartan plays a fungistatic and fungicidal activity against candida albicans biofilms: drug repurposing for localized candidosis
- Avaliação da expressão da enzima óxido nítrico-sintase induzível(INOS) por células CD68 positivas em doença periodontal humana
Informações sobre o DOI: 10.3389/fphar.2020.579926 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
